DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Cohort Study of the Clinical Course of Macular Diseases in Japanese

Information source: Kyoto University, Graduate School of Medicine
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Macular Disease

Intervention: ranibizumab, aflibercept, pegaptanib, verteporphin (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Kyoto University, Graduate School of Medicine

Official(s) and/or principal investigator(s):
Nagahisa Yoshimura, MD, Study Chair, Affiliation: Kyoto University, Graduate School of Medicine

Overall contact:
Akitaka Tsujikawa, MD, Phone: +81-75-751-3260, Email: tujikawa@kuhp.kyoto-u.ac.jp

Summary

Recent clinical introduction of anti-vascular endothelial growth factor agents may change the clinical course of macular diseases, including age-related macular degeneration (AMD), polypoidal choroidal vasculopathy (PCV), retinal angiomatous proliferation (RAP), central serous chorioretinopathy (CSC), myopic choroidal neovascularization (CNV), retinal vein occlusion (RVO), diabetic macular edema (DME), and so forth. Patients with such macular diseases are registered and and are followed up for 5 years with appropriate treatment for each patient. By the analysis of the correlation between initial examinations and final visual acuity, factors associated with good visual prognosis will be elucidated.

Clinical Details

Official title: Cohort Study of the Clinical Course of Macular Diseases in Japanese Patients

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Initial factors associated with visual prognosis in each macular disease

Secondary outcome: The difference in the visual prognosis depending on the treatments in each macular diseases

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients who visit Department of Ophthalmology Kyoto University Hospital with macular

diseases.

- Patients who are agreed with the participation of this study.

Exclusion Criteria:

- None

Locations and Contacts

Akitaka Tsujikawa, MD, Phone: +81-75-751-3260, Email: tujikawa@kuhp.kyoto-u.ac.jp

Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan; Recruiting
Misao Ogaki, Phone: +81-75-751-3248, Email: misao@kuhp.kyoto-u.ac.jp
Akitaka Tsujikawa, MD, Principal Investigator
Additional Information

Starting date: March 2014
Last updated: March 6, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017